On November 11, ILUVATAR COREX rose 3.57% in regular trading, trading at HK$72.95, with turnover of HK$52.02 million.
The move follows continued market focus on the companys recent disclosure that third-party testing showed its TianGai 300 achieved 1.05 times the end-to-end throughput of a leading international GPU under a typical PD-separated deployment, while its IXL144 supernode can reduce cost per million effective tokens by about 40% versus mainstream international alternatives.
Supporting context includes the companys earlier statement that chip shipments exceeded 80,000 units in the first 10 months, while first-half revenue reached RMB946 million, up 191.6% year over year. The combination of product validation, cost competitiveness and shipment growth has been the main publicly visible backdrop for recent share-price strength.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments